HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyewhon Rhim Selected Research

serotonin 6 receptor

2/2019Physical and Functional Interaction between 5-HT6 Receptor and Nova-1.
9/2014Effect of acute and chronic electroconvulsive shock on 5-hydroxytrypamine 6 receptor immunoreactivity in rat hippocampus.
9/2013Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
7/2011ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors.
3/2010Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyewhon Rhim Research Topics

Disease

18Alzheimer Disease (Alzheimer's Disease)
01/2024 - 03/2010
9Neurodegenerative Diseases (Neurodegenerative Disease)
04/2022 - 01/2007
9Neuralgia (Stump Neuralgia)
11/2016 - 01/2007
8Neoplasms (Cancer)
03/2021 - 10/2006
6Amyloid Plaque
04/2022 - 12/2016
5Pain (Aches)
09/2015 - 12/2010
4Memory Disorders (Memory Loss)
04/2022 - 03/2010
3Obesity
10/2021 - 12/2011
3Parkinson Disease (Parkinson's Disease)
03/2021 - 07/2017
3Cognitive Dysfunction
01/2020 - 12/2011
3Spinal Cord Injuries (Spinal Cord Injury)
09/2015 - 02/2003
3Cardiovascular Diseases (Cardiovascular Disease)
07/2010 - 12/2006
2Brain Diseases (Brain Disorder)
03/2021 - 03/2010
2Psychotic Disorders (Schizoaffective Disorder)
02/2019 - 01/2014
2Feeding and Eating Disorders (Eating Disorder)
02/2019 - 01/2014
2Inflammation (Inflammations)
01/2017 - 04/2012
2Hyperalgesia
11/2013 - 12/2010
1Arthritis (Polyarthritis)
01/2024
1Mental Disorders (Mental Disorder)
11/2022
1Atrophy
04/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2021
1Huntington Disease (Huntington's Disease)
03/2021
1Autistic Disorder (Autism)
01/2021
1Dementia (Dementias)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
12/2020
1Dehydration (Water Stress)
05/2020
1Prostatic Neoplasms (Prostate Cancer)
03/2020
1Hypoxia (Hypoxemia)
05/2019
1Mood Disorders (Mood Disorder)
02/2019
1Neuroinflammatory Diseases
01/2019
1Nervous System Diseases (Neurological Disorders)
01/2019
1Atopic Dermatitis (Atopic Eczema)
01/2017

Drug/Important Bio-Agent (IBA)

15gintoninIBA
01/2024 - 12/2016
10Proteins (Proteins, Gene)FDA Link
11/2022 - 04/2015
9Lysophosphatidic Acid ReceptorsIBA
01/2024 - 12/2016
7Amyloid (Amyloid Fibrils)IBA
04/2022 - 04/2015
6LigandsIBA
04/2021 - 12/2011
5lysophosphatidic acidIBA
05/2021 - 12/2016
5serotonin 6 receptorIBA
02/2019 - 03/2010
5T-Type Calcium Channels (T-Type Calcium Channel)IBA
12/2013 - 10/2006
4Antidepressive Agents (Antidepressants)IBA
09/2014 - 05/2013
3Ion Channels (Ion Channel)IBA
01/2021 - 01/2007
3PhytochemicalsIBA
01/2021 - 11/2020
3CalciumIBA
01/2020 - 05/2004
3serotonin 7 receptorIBA
11/2016 - 11/2013
3Analgesics (Analgesic Drugs)IBA
09/2015 - 12/2010
3Formaldehyde (Formol)FDA Link
11/2012 - 08/2010
2Cholinergic Agents (Cholinergics)IBA
04/2021 - 10/2018
2AntioxidantsIBA
03/2021 - 03/2021
2Peptides (Polypeptides)IBA
12/2020 - 07/2017
2GinsenosidesIBA
05/2020 - 01/2007
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2020 - 05/2004
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 12/2010
2SynucleinsIBA
01/2019 - 07/2017
2Serotonin (5 Hydroxytryptamine)IBA
09/2014 - 01/2014
2KYS 05090IBA
12/2013 - 07/2008
2Voltage-Gated Sodium ChannelsIBA
11/2013 - 11/2012
2Serotonin ReceptorsIBA
07/2011 - 03/2010
1Nerve Growth Factors (Neurotrophins)IBA
01/2024
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2024
1LipidsIBA
11/2022
1sargahydroquinoic acidIBA
10/2021
1Oxidopamine (6 Hydroxydopamine)IBA
10/2021
1gamma-Aminobutyric Acid (GABA)IBA
10/2021
1Evans Blue (Blue, Evans)FDA Link
04/2021
1SterolsIBA
03/2021
1puag-haadIBA
03/2021
1Free RadicalsIBA
03/2021
1GTP-Binding Proteins (G-Protein)IBA
03/2021
1Carrier Proteins (Binding Protein)IBA
01/2021
1Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2021
1NeurograninIBA
01/2021
1afzelinIBA
01/2021
1GTP Phosphohydrolases (GTPases)IBA
01/2021
1Glutamate Receptors (Glutamate Receptor)IBA
01/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1postsynaptic density proteinsIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
12/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020
1tau Proteins (tau Protein)IBA
12/2020
1Heavy MetalsIBA
12/2020
1ginsenoside Rk1IBA
05/2020
1ginsenoside Rg3IBA
05/2020
1Insulin (Novolin)FDA Link
03/2020
1AcetylglucosamineIBA
01/2019
1Threonine (L-Threonine)FDA Link
01/2019
1TransferasesIBA
01/2019
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2019
1Heme Oxygenase-1IBA
01/2019
1EnzymesIBA
01/2019
1hexosaminidase CIBA
01/2019
1Serine (L-Serine)FDA Link
01/2019
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
09/2015

Therapy/Procedure

4Oral Administration
04/2021 - 01/2017
2Therapeutics
09/2015 - 05/2013
1Denervation
10/2021
1Drug Therapy (Chemotherapy)
01/2021